Pros And Cons Of A CMS-FDA Parallel Review Program
On Friday, Oct. 7, 2011, the Centers for Medicare and Medicaid Services and the U.S. Food and Drug Administration (collectively, the "agencies") announced they were soliciting nominations from sponsors of medical...To view the full article, register now.
Already a subscriber? Click here to view full article